168.79
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$166.22
Offen:
$165.59
24-Stunden-Volumen:
330.24K
Relative Volume:
0.32
Marktkapitalisierung:
$10.22B
Einnahmen:
$17.76B
Nettoeinkommen (Verlust:
$1.55B
KGV:
7.0305
EPS:
24.0082
Netto-Cashflow:
$912.69M
1W Leistung:
+12.97%
1M Leistung:
+14.75%
6M Leistung:
-15.70%
1J Leistung:
+3.62%
Universal Health Services Inc Stock (UHS) Company Profile
Firmenname
Universal Health Services Inc
Sektor
Branche
Telefon
(610) 768-3300
Adresse
367 S GULPH RD, KING OF PRUSSIA, PA
Compare UHS vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
UHS
Universal Health Services Inc
|
168.78 | 9.64B | 17.76B | 1.55B | 912.69M | 24.01 |
|
HCA
Hca Healthcare Inc
|
415.80 | 86.43B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
259.74 | 20.96B | 21.46B | 2.65B | 3.35B | 19.23 |
|
DVA
Davita Inc
|
241.98 | 15.17B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.82 | 13.36B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
EHC
Encompass Health Corp
|
115.21 | 11.30B | 6.07B | 793.80M | 464.40M | 5.9914 |
Universal Health Services Inc Stock (UHS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-06-01 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2026-04-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2026-01-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-11-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-10-14 | Fortgesetzt | Goldman | Neutral |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-02-03 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-12-16 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-06 | Fortgesetzt | BofA Securities | Neutral |
| 2024-10-16 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-07-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-07-26 | Hochstufung | Cantor Fitzgerald | Underweight → Neutral |
| 2024-06-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-20 | Hochstufung | UBS | Neutral → Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-11 | Hochstufung | Goldman | Sell → Buy |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-30 | Hochstufung | SVB Securities | Market Perform → Outperform |
| 2023-04-25 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Underweight |
| 2023-04-19 | Eingeleitet | JP Morgan | Neutral |
| 2023-03-01 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-01-24 | Hochstufung | UBS | Sell → Neutral |
| 2023-01-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-12-16 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Hold |
| 2022-03-29 | Eingeleitet | Wells Fargo | Underweight |
| 2022-02-28 | Herabstufung | Seaport Research Partners | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-09-24 | Eingeleitet | UBS | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-09-08 | Herabstufung | Goldman | Neutral → Sell |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Underweight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-06-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-01-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-12-15 | Eingeleitet | Goldman | Neutral |
| 2020-09-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-06-09 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-23 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-26 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-04 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-07-18 | Herabstufung | Goldman | Buy → Neutral |
| 2018-01-30 | Fortgesetzt | Wells Fargo | Outperform |
| 2018-01-03 | Eingeleitet | Goldman | Buy |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-10-11 | Eingeleitet | Stephens | Equal-Weight |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2017-04-27 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-27 | Hochstufung | Mizuho | Neutral → Buy |
Alle ansehen
Universal Health Services Inc Aktie (UHS) Neueste Nachrichten
Tranche Update on Universal Health Services, Inc.'s Equity Buyback Plan announced on July 24, 2014. - marketscreener.com
UHS: Q2 2026 delivered robust volume growth, updated guidance, and accelerated share repurchases - TradingView
UHS: Q2 2026 delivered higher EPS and EBITDA, with robust demand but revised guidance amid liability headwinds - TradingView
Earnings call transcript: Universal Health Services misses Q2 EPS forecast - Investing.com
UHS Beats Q2 Earnings and Revenue Estimates Despite Cost Pressures - TradingView
UHS Maintained by Barclays -- Price Target Lowered to $168 - GuruFocus
Is Universal Health Services Inc (UHS) Undervalued After Q2 Earn - GuruFocus
Universal Health Services reports Q2 revenue $4.64B, adjusted EPS $5.98; revises 2026 outlook - TradingView
Why Is Universal Health Services (NYSE:UHS) Stock Drawing Fresh Market Interest Today? - Kalkine Media
Universal Health Services, Inc. Stock 12‑Month Price Target Cut to $203.75, Implies 28% Upside - TradingView
Boeing, Coca-Cola And 3 Stocks To Watch Heading Into Tuesday - Benzinga
What Happened in Universal Health Services (NYSE:UHS) Q2 Results? - Kalkine Media
Universal Health Services (UHS) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance Australia
UHS: Q2 2026 net income rose to $358.4M on 8.3% higher revenues; 2026 outlook revised downward - TradingView
Universal Health Services cuts 2026 forecast on Medicaid reimbursement uncertainty - Reuters
UHS Looks 30.8% Undervalued on GF Value™ - GuruFocus
Universal Health Services (UHS) Q2 Earnings and Revenues Top Estimates - Yahoo Finance UK
Why is Universal Health Services stock sliding today? - Investing.com
Universal Health Services Inc. Cl B stock outperforms competitors on strong trading day - MarketWatch
Universal Health Services Q2 Earnings, Revenue Rise; Lowers FY26 Guidance - marketscreener.com
Universal Health Services slips as EPS guidance lowered, Q2 bottom line missed - Seeking Alpha
(UHS) Universal Health Services Now Expects 2026 Revenue Range $18.50B-$18.76B, vs. FactSet Est of $18.53B - marketscreener.com
Universal Health Services cuts FY26 EPS guidance to $22.28-$23.65 - scanx.trade
Universal Health Services (NYSE:UHS) Surprises With Q2 CY2026 Sales But Stock Drops - StockStory
Universal Health shares slide 7% on Q2 earnings miss By Investing.com - Investing.com Nigeria
Universal Health shares slide 7% on Q2 earnings miss - Investing.com
Universal Health Services earnings missed by $0.60, revenue topped estimates - Investing.com Canada
Universal Health Services: Q2 Earnings Snapshot - AOL.com
Earnings Flash (UHS) Universal Health Services, Inc. Reports Q2 Revenue $4.64B, vs. FactSet Est of $4.58B - marketscreener.com
UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026, AND REVISES 2026 FULL YEAR OPERATING RESULTS FORECAST - Yahoo Finance
OAG probe clouds transfer of George Washington University doctors' group as deadline looms - The Business Journals
Universal Health Services faces earnings test on volume expectations - Investing.com
Universal Health stock trades steadily as recent earnings highlight margin resilience - Ad-hoc-news.de
Universal Health Services (UHS) Stock Looks Undervalued As Shares Fell 29% YTD - Yahoo Finance
Universal Health Services (UHS) Set to Report Q2 Earnings with S - GuruFocus
How UHS’s New US$700 Million Short-Term Loan and Dividend Move Has Changed Its Investment Story - Yahoo Finance
Universal Health Services (UHS) Q2 Earnings: What To Expect - Yahoo Finance
Universal Health stock trades steady as investors weigh recent earnings and debt reduction progress - Ad-hoc-news.de
Universal Health Services Inc. (UHS) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Booz Allen Hamilton Posts Upbeat Q1 Earnings, Joins Tenet Healthcare, SS&C Technologies And Other Big Sto - Benzinga
Universal Health stock trades steadily as earnings and margins frame the next move - AD HOC NEWS
Healthcare Stocks: Three US Companies Remain in Focus - Kalkine Media
Does UHS’s New $700 Million Term Loan and Dividend Shift Its Capital Allocation Priorities? - simplywall.st
Can Acute Care Strength Offset Universal Health's Rising Q2 Costs? - TradingView
Universal Health Services Faces Lawsuit Over Abuse at Missouri Hospital - The Capitol Forum
Universal Health Care | Pros, Cons, Debate, Arguments, Medicare, Medicaid, & Insurance - Encyclopedia Britannica
Universal Health Services declares $0.20 dividend - MSN
Universal Health Services (UHS) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
Universal Health Services (UHS) Announces Twelfth Amendment to C - GuruFocus
Universal Health ServicesEnters Twelfth Amendment To Credit Agreement On July 20, 2026SEC Filing - TradingView
Universal Health Services, Inc. Enters into Twelfth Amendment to Credit Agreement, Adds $700 million Senior Secured Delayed Draw Term Loan Facility - marketscreener.com
Finanzdaten der Universal Health Services Inc-Aktie (UHS)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):